cFMS Receptor Inhibitor IV

CAS No. 959626-45-0

cFMS Receptor Inhibitor IV( 5-cyano-N-(2,5-di(piperidin-1-yl)phenyl)furan-2-carboxamide )

Catalog No. M28536 CAS No. 959626-45-0

cFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 33 In Stock
5MG 53 In Stock
10MG 88 In Stock
25MG 183 In Stock
50MG 276 In Stock
100MG 461 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    cFMS Receptor Inhibitor IV
  • Note
    Research use only, not for human use.
  • Brief Description
    cFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.
  • Description
    cFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    5-cyano-N-(2,5-di(piperidin-1-yl)phenyl)furan-2-carboxamide
  • Pathway
    Tyrosine Kinase
  • Target
    CSF1R
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    959626-45-0
  • Formula Weight
    378.47
  • Molecular Formula
    C22H26N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 31.25 mg/mL (82.57 mM)
  • SMILES
    N#CC=1OC(=CC1)C(=O)NC2=CC(=CC=C2N3CCCCC3)N4CCCCC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AZD7507

    AZD7507 (AZD-7507) is a potent, selective, orally available CSF-1R (c-FMS) with IC50 of 32 nM.

  • Plonmarlimab

    Plonmarlimab (TJ003234) is an anti-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody with potential antiviral activity for the study of immune diseases and novel coronavirus infections.

  • Axatilimab

    Axatilimab (SNDX-6352) is a human IgG4 antibody targeting the colony-stimulating factor 1 receptor (CSF-1R), which can be used for the study of immune system disorders and respiratory diseases.